AKT1 and breast carcinoma: The PI3K/Akt/mTOR pathway play an important role in carcinogenesis and apoptosis resistance, promoting tumor growth and proliferation, and the activation of phosphatidyl-inositol 3-kinase (PI3K) has been associated with endocrine resistance, a major problem in the treatment of breast cancer [16,17,18].